About Celine Lam

This author has not yet filled in any details.
So far Celine Lam has created 47 blog entries.

How to Qualify Sterile Fill Line Equipment: Key Steps and Best Practices for Compliance

Discover key steps for equipment qualification of sterile fill line equipment, ensuring FDA compliance with best practices from installation to performance qualification.

2024-11-04T19:33:59+00:00October 23rd, 2024|Industry Expertise, LinkedIn|

Driving Continuous Improvement in FDA-Regulated Industries: Strategies to Prevent FDA Form 483 Issues

Prevent FDA Form 483 issues with expert strategies in compliance, data integrity, and quality systems from cGMP Consulting.

2024-11-11T18:31:09+00:00October 21st, 2024|Audits, Industry Expertise, LinkedIn|

Proven Data Integrity Practices for CQV: Ensuring Compliance in Equipment Qualification

Ensure data integrity during Commissioning, Qualification, and Validation (CQV) with proven practices from cGMP Consulting. Learn how we address FDA concerns, implement automated systems, and follow ALCOA+ principles to maintain data accuracy and compliance in equipment qualification.

2024-11-04T19:39:34+00:00October 17th, 2024|Industry Expertise, LinkedIn|

The True Cost of Receiving an FDA Form 483: A Breakdown of Financial and Operational Risks

Uncover the financial and operational risks of an FDA Form 483, from costly remediation to reputation damage. Learn how cGMP Consulting can help mitigate these impacts and ensure compliance.

2024-11-04T19:39:13+00:00October 14th, 2024|Audits, Industry Expertise, LinkedIn|

A Step-by-Step Guide to Equipment Qualification in a New Facility

Step-by-step guide to equipment qualification for FDA compliance, covering Installation, Operational, and Performance Qualification (IQ, OQ, PQ) and maintaining product quality in new facilities.

2024-11-04T21:01:24+00:00October 10th, 2024|Industry Expertise, LinkedIn|

Immediate Steps to Take After Receiving an FDA Form 483: Don’t Risk a Warning Letter

Learn the key steps to take after receiving an FDA Form 483 to avoid a Warning Letter, including swift response, CAPA plan development, and maintaining FDA communication.

2024-11-04T21:01:47+00:00October 7th, 2024|Audits, Industry Expertise, LinkedIn|

Understanding Commissioning, Qualification, and Validation (CQV): Ensuring Compliance in cGMP Environments

Learn about Commissioning, Qualification, and Validation (CQV) in cGMP environments to ensure compliance and product quality in the pharmaceutical industry.

2024-11-04T21:03:22+00:00October 1st, 2024|Industry Expertise, LinkedIn|

Immediate Steps for MoCRA GMP Compliance: What Cosmetic Manufacturers Can Start Today

Prepare for MoCRA GMP compliance with cGMP Consulting. Get expert help with assessments, SOPs, and training for early compliance and reduced risks.

2024-11-04T21:02:53+00:00September 17th, 2024|Industry Expertise, LinkedIn, MoCRA|

Your How-to Guide: Seamless Implementation of Electronic GMP Systems

Discover how to seamlessly implement electronic GMP systems with expert consulting from cGMP Consulting and amni.ai. Enhance compliance and operational efficiency in FDA-regulated industries.

2024-11-04T21:03:17+00:00August 27th, 2024|Industry Expertise, LinkedIn, MoCRA|
Go to Top